Free Delivery Over $100
|
|
|||
|
||||
OverviewFull Product DetailsAuthor: Kerry J. Ressler (MD, PhD, Professor, MD, PhD, Professor, Center for Behavioral Neuroscience, Department of Psychiatry and Behavioral Sciences, Yerkes Research Ctr, Emory University) , Daniel S. Pine (MD, Chief, MD, Chief, Section on Development and Affective Neuroscience, Mood and Anxiety Disorders Program, Intramural Research Program, National Institute of Mental Health) , Barbara Olasov Rothbaum (PhD, Professor, PhD, Professor, Emory University School of Medicine, Department of Psychiatry and Behavioral Sciences)Publisher: Oxford University Press Inc Imprint: Oxford University Press Inc Dimensions: Width: 17.80cm , Height: 2.60cm , Length: 25.30cm Weight: 0.924kg ISBN: 9780199395125ISBN 10: 0199395128 Pages: 528 Publication Date: 21 May 2015 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: To order  Stock availability from the supplier is unknown. We will order it for you and ship this item to you once it is received by us. Table of ContentsForeword: Anxiety Disorders, Big Science, and Big Data: The Next Generation of Science and Practice Section 1: Overview of Anxiety and Related Illnesses 1. Anxiety and Related Disorders in DSM5. 2. Translational Perspectives, RDoC and Anxiety. Section 2: Neurobiology and Neural Circuitry of Anxiety Disorders 3. Neurobiology and Neuroimaging of Fear and Anxiety Circuitry. 4. The Genetics of Anxiety Disorders. Section 3: Development of Fear, Fear Pathways, and Anxiety Disorders in Children and Adolescents 5. Developmental Biology related to Emotion and Anxiety. 6. Development of Fear and its Inhibition 7. Involving the Family in Treatment. 8. Treating the College-age Patient. Section 4: Posttraumatic Stress and the Neurobiology of Trauma 9. PTSD and the Biology of the Stress Response. 10. Clinical Aspects of Trauma-related Anxiety and PTSD. Section 6: Obsessive Compulsive and Disorders of Cortical-Striatal Processing 11. Dissecting OCD Circuits: From Animal Models to Targeted Treatments. 12. Clinical aspects of Obsessive Compulsive Disorder. Section 7: Phobias, Fears, and Panic 13. The Etiology of Fear and Anxiety: The Role of Environmental Exposures. 14. Clinical Aspects of Social Anxiety Disorder and Specific Phobias. 15. Clinical aspects of Panic disorder. Section 8: Intersection of Medical and Anxiety Disorders 16. Fear, Anxiety, Avoidance, and Chronic Pain. 17. Detection and Treatment of Anxiety Disorders in Primary Care Settings. 18. Gastrointestinal Disorders, Irritable Bowel Syndrome, and Anxiety. 19. Anxiety Disorders and Cardiovascular Illness. Section 9: Intersection of Anxiety with Mood and Substance Disorders 20. Substance abuse and Comorbidity with Anxiety. 21. Comorbidity of Anxiety and Depression. 22. Generalized Anxiety Disorder. 23. Anxiety and Suicide. Section 10: Cognitive and Exposure Based Treatments of Anxiety Disorders 24. Neural Circuitry Mechanisms of Fear Extinction. 25. Learning Theory and Cognitive Behavioral Therapy. 26. Pharmacological Mechanisms of Modulating Fear and Extinction. Section 11: Neurotransmitter Pathways and Pharmacological Treatments of Anxiety Disorders 27. Stress, Anxiety, Depression and the Role of Glutamate Neurotransmission. 28. The Role of the Hypothalamic-Pituitary-Adrenal Axis in Anxiety Disorders. 29. Pharmacological Interventions for Adult Anxiety Disorders. Section 12: New Technologies and Approaches to Treatment 30. Adherence to Psychotherapy and Pharmacotherapy for Anxiety Disorders. 31. Computer Tools as Novel Treatment for Depression and Anxiety. 32. Internet-Based Treatment for Anxiety, OCD, and Related Disorders.ReviewsAll clinicians and clinical scientists working in anxiety disorders who would like a vision of where the field will be in 5 to 10 years should read this Primer. With three of the leading clinical investigators in the world as Editors, and with a first-rate roster of contributors covering all the latest findings from neurotransmitter underpinnings of drug treatments to the neuroscience of psychological treatments, readers can preview likely changes in diagnosis, assessment, and treatment in the years to come. Most importantly, we get a glimpse of a future in which we can individualize treatment based on a sound set of scientifically validated predictors of outcome. A must read! - David H. Barlow PhD, ABPP, Professor of Psychology and Psychiatry, Boston University, Founder and Director Emeritus, Center for Anxiety and Related Disorders, Boston, MA The study of anxiety, once the foundational concept for all psychopathology, maps the path for the future of all psychiatric neuroscience and psychobiology, revealing the rich interplay of nature, nurture and development, and yielding therapeutic advances in psychotherapies, psychopharmacology and neurotherapeutics. The publishers, editors and authors of this volume, and the pioneering organization that has brought them together, the ADAA, have delivered a comprehensive, essential and useful volume for the field. - Jerrold F. Rosenbaum, MD, Chief of Psychiatry, Massachusetts General Hospital; Stanley Cobb Professor of Psychiatry, Harvard Medical School, Boston, MA Among the book's many strengths are its readability, the focus on the important, need-to-know material, and comprehensive summaries of cited research. Doody's Notes All clinicians and clinical scientists working in anxiety disorders who would like a vision of where the field will be in 5 to 10 years should read this Primer. With three of the leading clinical investigators in the world as Editors, and with a first-rate roster of contributors covering all the latest findings from neurotransmitter underpinnings of drug treatments to the neuroscience of psychological treatments, readers can preview likely changes in diagnosis, assessment, and treatment in the years to come. Most importantly, we get a glimpse of a future in which we can individualize treatment based on a sound set of scientifically validated predictors of outcome. A must read! - David H. Barlow PhD, ABPP, Professor of Psychology and Psychiatry, Boston University, Founder and Director Emeritus, Center for Anxiety and Related Disorders, Boston, MA The study of anxiety, once the foundational concept for all psychopathology, maps the path for the future of all psychiatric neuroscience and psychobiology, revealing the rich interplay of nature, nurture and development, and yielding therapeutic advances in psychotherapies, psychopharmacology and neurotherapeutics. The publishers, editors and authors of this volume, and the pioneering organization that has brought them together, the ADAA, have delivered a comprehensive, essential and useful volume for the field. - Jerrold F. Rosenbaum, MD, Chief of Psychiatry, Massachusetts General Hospital; Stanley Cobb Professor of Psychiatry, Harvard Medical School, Boston, MA Author InformationKerry J. Ressler, Professor of Psychiatry and Behavioral Sciences at Emory University, received his B.S. degree in molecular biology from M.I.T., and his M.D./Ph.D. from Harvard Medical School. His work focuses on translational research bridging molecular neurobiology in animal models with human genetic research. His basic and clinical research examines neurobiological, molecular, genetic and behavioral processes that underlie fear related processing and Posttraumatic Stress Disorder. Dr. Daniel S. Pine is Chief, Section on Development and Affective Neuroscience, in the National Institute of Mental Health Intramural Research Program. Since graduating from medical school at the University of Chicago, Dr. Pine has been engaged continuously in research on pediatric mental disorders. Currently, his group examines the degree to which mood and anxiety disorders in children and adolescents are associated with abnormalities in the amygdala, prefrontal cortex, and brain regions that modulate these structures. Barbara Olasov Rothbaum, Ph.D. is a professor in psychiatry and Associate Vice Chair of Clinical Research at the Emory School of Medicine in the Department of Psychiatry and Behavioral Sciences and director of the Trauma and Anxiety Recovery Program at Emory. Dr. Rothbaum specializes in research on the treatment of individuals with anxiety disorders, particularly focusing on Posttraumatic Stress Disorder (PTSD). Tab Content 6Author Website:Countries AvailableAll regions |
||||
